University Of Tasmania
124402.pdf (4.2 MB)

TRPC1 is a differential regulator of hypoxia-mediated events and Akt signalling in PTEN-deficient breast cancer cells

Download (4.2 MB)
journal contribution
posted on 2023-05-19, 16:14 authored by Iman AzimiIman Azimi, Milevskiy, MJG, Kaemmerer, E, Turner, D, Yapa, KTDS, Brown, MA, Thompson, EW, Roberts-Thomson, SJ, Monteith, GR
Hypoxia is a feature of the tumour microenvironment that promotes invasiveness, resistance to chemotherapeutics and cell survival. Our studies identify the transient receptor potential canonical-1 (TRPC1) ion channel as a key component of responses to hypoxia in breast cancer cells. This regulation includes control of specific epithelial to mesenchymal transition (EMT) events and hypoxia-mediated activation of signalling pathways such as activation of the EGFR, STAT3 and the autophagy marker LC3B, through hypoxia-inducible factor-1α (HIF1α)-dependent and -independent mechanisms. TRPC1 regulated HIF1α levels in PTEN-deficient MDA-MB-468 and HCC1569 breast cancer cell lines. This regulation arises from effects on the constitutive translation of HIF1α under normoxic conditions via an Akt-dependent pathway. In further support of the role of TRPC1 in EMT, its expression is closely associated with EMT- and metastasis-related genes in breast tumours, and is enhanced in basal B breast cancer cell lines. TRPC1 expression is also significantly prognostic for basal breast cancers, particularly those classified as lymph node positive. The defined roles of TRPC1 identified here could be therapeutically exploited for the control of oncogenic pathways in breast cancer cells.


Publication title

Journal of Cell Science










School of Pharmacy and Pharmacology


Company Of Biologists Ltd

Place of publication

Bidder Building Cambridge Commercial Park Cowley Rd, Cambridge, England, Cambs, Cb4 4Dl

Rights statement

Copyright 2017 The Authors

Repository Status

  • Restricted

Socio-economic Objectives

Clinical health not elsewhere classified